Mercer Island, WA, United States of America

Richard A Zager

This inventor holds 14 USPTO granted patents and 13 published patent applications and 2 EPO patents. Top assignees: Renibus Therapeutics, Inc., Fred Hutchinson Cancer Center. Active years: 2017-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Richard A Zager. Retrieved from https://idiyas.com/inventor/richard-a-zager

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 14 (Patent Applications = 13)

% Patents Active = 100.0

EPO Patents = 2 (Patent Applications = 6)

Average Co-Inventor Count = 2.7

ph-index = 2

Forward Citations = 11(Granted Patents)

Location History:

Mercer Island, WA (US) (2017 - 2022)
Seattle, WA (US) (2023 - 2024)

Company Filing History:

9 out of 11

Renibus Therapeutics, Inc.

patents

5 out of 309

Fred Hutchinson Cancer Center

patents

Years Active: 2017-2026

Loading Chart...

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12697311 - Tetrahydrocurcumin compositions, methods of making, and methods of using the same (2026-08-04),

2. 12178789 - Stress test and treatment of chronic kidney disease (2024-12-31),

3. 12115138 - Tetrahydrocurcumin compositions, methods of making, and methods of using the same (2024-10-15),

4. 12083145 - Compositions, kits, and methods to induce acquired cytoresistance using stress protein inducers (2024-09-10),

5. 11965896 - Methods of treating patients at risk for renal injury and renal failure (2024-04-23),

6. 11883371 - Stress test and treatment of chronic kidney disease (2024-01-30),

7. 11878029 - Compositions, kits, and methods to induce acquired cytoresistance using stress protein inducers (2024-01-23),

8. 11840552 - Iron compositions and methods of making and using the same (2023-12-12),

9. 11834471 - Iron compositions and methods of making and using the same (2023-12-05),

10. 11435364 - Methods of treating patients at risk for renal injury and renal failure (2022-09-06),

11. 11292813 - Iron compositions and methods of making and using the same (2022-04-05),

12. 10912793 - Compositions, kits, and methods to induce acquired cytoresistance using stress protein inducers (2021-02-09),

13. 10639321 - Compositions, kits, and methods to induce acquired cytoresistance using stress protein inducers (2020-05-05),

14. 9844563 - Compositions, kits, and methods to induce acquired cytoresistance using stress protein inducers (2017-12-19),

Title: The Innovative Contributions of Richard A. Zager

Introduction

Richard A. Zager is a prominent inventor based in Mercer Island, WA (US), known for his significant contributions to medical science. With a total of 13 patents to his name, Zager has focused on developing innovative solutions for chronic kidney disease and other therapeutic applications. His work exemplifies the intersection of creativity and scientific research.

Latest Patents

Zager's latest patents include groundbreaking inventions aimed at improving patient care. One notable patent is for a method of stress testing and treatment of chronic kidney disease. This invention involves administering a compound that induces a stress protein response in patients, along with a potent antioxidant if the patient's response is below a predefined level. Additionally, it introduces a quantitative measure for determining a patient's antioxidant reserve capacity. Another significant patent is related to tetrahydrocurcumin compositions, which details novel methods of manufacturing and using these compositions for therapeutic applications. This invention results in tetrahydrocurcumin compositions that generally lack hexahydrocurcumin and feature an improved impurity profile.

Career Highlights

Throughout his career, Richard A. Zager has worked with notable organizations that have contributed to his research and development efforts. He has been associated with Renibus Therapeutics, Inc. and the Fred Hutchinson Cancer Center, where he has collaborated with leading experts in the field. His work has not only advanced scientific understanding but has

Profile summary based on public USPTO records.